We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Sickothetech go back to your Totally useless board, we're not interested in anything you say on here or Hvivo. Just cause your Totally shares are down 95% and the CFO has resigned due to perilous cash position! JMO Adyor
Latest AR available, fy2022, showed they had zero revenues, yet costs have increased.
Fy2023 ended 4 months ago and still no results. Last year they announced them on 30th March.
Looking at the price around 15.06 the 1,000,000 trade looks like another buy?
There hasn't been much negative feedback from today's RNS, looking at the volumes brought vs sold - it looks a like a bit of tree shake to me. Thoughts?
4.8% holding on 15th March. Further stake building since. They can declare whenever they like. Buy now for long term gains.
Is it the Michael Kelly that was involved in the sale of adapt Pharma.
RNS out of major holding 4.8%.
Where's the fy results?
Previously fy results were announced:
fy2021 03/03/22
fy2022 30/03/23
500k will cost you 12.5p - strong buy under 12p at the moment
Someone keen again today, 100k buy at the opening bell, 950k on Wednesday at 11.90p and a lot of large buys all week, is something in the pipeline or someone stake building?
Let’s hope it is also a decent Q&A session.
As regards getting noticed once any meaningful contacts arrive should be the case.
It’s been a slow burn so far however things take longer to put in place so to speak.
All I he pieces are still there just as and when news drops.
We are in good hands in that we trust JS seems a really likable guy with a excellent background.
Any of you people,also invested in EGT?
I can see us going into the 12p+ tomorrow for any volume
I might even buy a few more under 12p will look very cheap
Cathal Friel`s 11.68p buy is starting to look cheap now for that amount now near 13p
I see the 10% ers are bailing out again looking to get in again on any pullback....I must try it myself sometime Silverhorse MaryB...
Hopefully a good turnout to get behind this company.
Listened to the podcast on my morning run. Very illuminating about JS and his motivations. Very likeable chap and can walk the walk on the science and seems well connected in the space we need to be. Has certainly been involved in DD for acquisiation and been involved in getting a company sold. Definately a bloke I could sit and have a pint with - I think a few here under estimate JS. Pharma deals take time and are unpredictable. See destiny pharma as a prime example. Flavour of the.month and riding high with really good p2 data but struggling to get a decent value deal. Good product but cold space and antibiotics are really tricky to get approved and business model hard for big pharma to stand as antibiotics are designed to work and ideally not be used again as patient gets better so rpt sales rely on new patient. With Cart and bispecific antibodies the space is really hot and will form backbone of cancer therapy for a good few decades. The cart therapy is eye watering in cost even with recent economic savings as these therapies scale. Polb001 could be just the right drug at right time. Pharma investment is tough for those on board and most PI have expectations above reality. Poolbeg in some interesting spaces and I am just hoping in licensing from the ex amryt team of cleared assets that generate income don't cost us too.much dilution
Thanks NBucky1 for organising this. Looking forward to some pressing blunt questioning. I think it is high time that we are given more information on the structure of the potential deal that we have been led to believe is in the making this year.
Could well be Halls just topped my ISA this morning bolds well.
European Green Transition - Monday 29th April 2024 @ 6pm
https://stream.brrmedia.co.uk/broadcast/662910f2fac95cca98c0ba87
Poolbeg Pharma plc - Wednesday 1st May 2024 @ 6pm
https://stream.brrmedia.co.uk/broadcast/662916cdfac95cca98c0bb60
This will include an overview of the companies by the CEO's and a brief chat with Cathal Friel. It will be concluded with a Q&A session.
All investors/non-investors are invited to these great webinars.
Sign up and pre-submit questions
Probably another director buy
Late reported trades Wow some purchase 950,000 shares at 11.90p
Silverhorse, get back in you stable, you ramping yet again.
Such a shame when a rise in the share price attracts the idiots